A low dose cell therapy system for treating osteoarthritis: In vivo study and in vitro mechanistic investigations.
Bioactive materials
Wang B, Liu W, Li JJ, Chai S, Xing D, Yu H, Zhang Y, Yan W, Xu Z, Zhao B, Du Y, Jiang Q.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2022
Cell Counting & Viability
No items found.
Key Finding
Co-culture supernatants subjected to secretome analysis showed significant decrease of inflammatory factors in the 3D group. The cell delivery platform the authors investigated may be effective in reducing the cell dose and injection frequency required for therapeutic applications.
Countstar Connection
Cell number and viability were measured in the study's cell samples with Countstar (model not specified) during quality assessment in the 2022 Bioactive materials study.
